Genmab A/S
GMAB
ISIN null / Valor 21487099
Genmab A/S
UMushroom community rating:
About company
Genmab A/S, founded in 1999 in Copenhagen, Denmark, is a dual-listed, international biotechnology company focused on the creation and development of differentiated antibody therapeutics to combat cancer and other serious diseases. The company's primary goal is to develop innovative treatments that address unmet medical needs and improve patient outcomes. With a strong emphasis on research and development, Genmab A/S is dedicated to advancing the field of biotechnology and making a positive impact on global healthcare.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
Performance
Volatility
15910 M
Market cap (USD)
1,816,156
Daily traded volume (Shares)
20.87 / 20.69
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
